Suture-based vs. pure plug-based vascular closure devices for VA-ECMO decannulation-A retrospective observational study.
MANTA
ProGlide
VA-ECMO
cardiogenic shock
plug-based closure device
suture-based closure device
veno-arterial extracorporeal membrane oxygenation
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2023
2023
Historique:
received:
23
11
2022
accepted:
10
01
2023
entrez:
13
2
2023
pubmed:
14
2
2023
medline:
14
2
2023
Statut:
epublish
Résumé
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a valuable treatment option for patients in cardiogenic shock, but complications during decannulation may worsen the overall outcome. Therefore, the aim of this study was to compare the efficacy and safety of suture-based to pure plug-based vascular closure devices for VA-ECMO decannulation. In this retrospective study, the procedural outcome of 33 patients with suture-based Rate of technically correct placement of closure devices was 88% in the suture-based group and 97% in the plug-based group ( Based on our retrospective analysis, we propose that plug-based vascular closure should be the preferred option for VA-ECMO decannulation. This hypothesis should be further tested in a randomized trial.
Sections du résumé
Background
UNASSIGNED
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a valuable treatment option for patients in cardiogenic shock, but complications during decannulation may worsen the overall outcome. Therefore, the aim of this study was to compare the efficacy and safety of suture-based to pure plug-based vascular closure devices for VA-ECMO decannulation.
Methods
UNASSIGNED
In this retrospective study, the procedural outcome of 33 patients with suture-based
Results
UNASSIGNED
Rate of technically correct placement of closure devices was 88% in the suture-based group and 97% in the plug-based group (
Conclusion
UNASSIGNED
Based on our retrospective analysis, we propose that plug-based vascular closure should be the preferred option for VA-ECMO decannulation. This hypothesis should be further tested in a randomized trial.
Identifiants
pubmed: 36776253
doi: 10.3389/fcvm.2023.1106114
pmc: PMC9908581
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1106114Informations de copyright
Copyright © 2023 Scherer, Theiss, Istrefi, Binzenhöfer, Kupka, Stocker, Lüsebrink, Stambollxhiu, Alemic, Petzold, Stark, Deseive, Braun, Joskowiak, Peterss, Hausleiter, Hagl, Massberg and Orban.
Déclaration de conflit d'intérêts
CS and SD received speaker honoraria from AstraZeneca outside the submitted work. JH received speaker honoraria and research support from Abbott Vascular and Edwards Lifesciences outside the submitted work. MO received speaker honoraria from AstraZeneca, Abiomed, CytoSorbents, and Sedana Medical, outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Crit Care Explor. 2019 Jun 26;1(6):e0018
pubmed: 32166262
Perfusion. 2021 Nov;36(8):803-807
pubmed: 33200650
EuroIntervention. 2021 Aug 27;17(6):451-465
pubmed: 34413010
J Interv Cardiol. 2022 Mar 18;2022:9915247
pubmed: 35360094
JAMA. 2021 Nov 09;326(18):1840-1850
pubmed: 34751704
Can J Cardiol. 2019 Jun;35(6):796.e9-796.e11
pubmed: 31151721
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Ann Thorac Surg. 2014 Feb;97(2):610-6
pubmed: 24210621
Thorac Cardiovasc Surg. 2021 Sep;69(6):537-541
pubmed: 34376000
N Engl J Med. 2012 Oct 4;367(14):1287-96
pubmed: 22920912
Indian Heart J. 2022 May-Jun;74(3):251-255
pubmed: 35367458
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
Cardiovasc Revasc Med. 2022 Apr;37:34-40
pubmed: 34257057
Circulation. 2022 Jan 18;145(3):170-183
pubmed: 34738828
N Engl J Med. 2018 Nov 1;379(18):1699-1710
pubmed: 30145971